| 1. |
- Lagerspetz, E., et al.
(författare)
-
Pervasive Communities in the Internet of People
- 2018
-
Ingår i: 2018 IEEE International Conference on Pervasive Computing and Communications Workshops, PerCom Workshops 2018. - : Institute of Electrical and Electronics Engineers Inc.. - 9781538632277 ; , s. 40-45
-
Konferensbidrag (refereegranskat)abstract
- The Internet has traditionally been a device-oriented architecture where devices with IP addresses are first-class citizens, able to serve and consume content or services, and their owners take part in the interaction only through those devices. The Internet of People (IoP) is a recent paradigm where devices become proxies of their users, and can act on their behalf. To realize IoP, new policies and rules for how devices can take actions are required. The role of context information grows as devices act autonomously based on the environment and existing social relationships between their owners. In addition, the social profiles of device owners determine e.g. how altruistic or resourceconserving they are in collaborative computing scenarios. In this paper we focus on community formation in IoP, a prerequisite for enabling collaborative scenarios, and discuss main challenges and propose potential solutions. © 2018 IEEE.
|
|
| 2. |
- Widgren, K, et al.
(författare)
-
Prevailing effectiveness of the 2009 influenza A(H1N1)pdm09 vaccine during the 2010/11 season in Sweden
- 2013
-
Ingår i: Eurosurveillance. - : eurosurveillance. - 1025-496X .- 1560-7917. ; 18:15, s. Article 5-
-
Tidskriftsartikel (refereegranskat)abstract
- Sixty per cent of the Swedish population received the monovalent AS03-adjuvanted pandemic influenza vaccine in the autumn of 2009. We assessed the age-specific effectiveness of this pandemic vaccine against hospitalisation with laboratory-confirmed influenza A(H1N1)pdm09 during the season 2010/11, in the age group from six months to 64 years in Sweden. The screening method was applied to available surveillance data. Our results suggest a prevailing effectiveness of 72% (95% confidence interval (CI): 63–80%) with the highest effectiveness among children, six months to nine years-old (92%, 95%CI: 80–97%). However, there were limitations in data quality and study design due to the lack of systematic recording of administered vaccinations, which underline the importance of preparing for an evaluation when planning for large public health actions. Despite these limitations, we believe the results reflect true, high prevailing vaccine effectiveness. Indeed, there were fewer deaths caused by influenza and the impact of influenza on intensive care units was less severe during the 2010/11 season in Sweden than in countries with lower pandemic vaccination coverage. The association between the pandemic vaccine and narcolepsy has increased the importance of assessing the risks and benefits of the vaccination; studies on the effectiveness and the duration of protection are needed for this.
|
|
